Tetsuo Matsuzaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tetsuo Matsuzaki has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Daisuke Mori
Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan; Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, 466-8550, Japan
1 shared publication - Hiroaki Ikesue
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan
1 shared publication Hiroyuki Mizoguchi
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine
1 shared publication- Hiroyuki Mizoguchi
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine
1 shared publication - Kanako Kitagawa
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan
1 shared publication Kiyofumi Yamada
Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1010, 178407
Cortical excitatory and inhibitory neuron deficits may underlie the cognitive and social impairments in a mouse model of schizophrenia with exonic Reln deletion
- 26 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1010, 178407
Open AccessCortical excitatory and inhibitory neuron deficits may underlie the cognitive and social impairments in a mouse model of schizophrenia with exonic Reln deletion
- Open Access
- 15 November 2024
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 47 (11) , 1883-1892
The Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug Monitoring
Therapeutic drug monitoring (TDM) is a routine clinical practice used to individualize drug dosing to maintain drug efficacy and minimize the consequences of overexposure. TDM is applied to many drug classes, including immunosuppressants, antineoplastic agents, and antibiotics. Considerable effort has been made to establish routine TDM practices for each drug. However, because TDM has been developed within the context of specific drugs, there is insufficient understanding of historical trends within the field of TDM research as a whole. In this study, we employed text-mining approaches to explore trends in the TDM research field. We first performed a PubMed search to determine which drugs and drug classes have been extensively studied in the context of TDM. This investigation revealed that the most commonly studied drugs are tacrolimus, followed by cyclosporine and vancomycin. With regard to drug classes, most studies focused on immunosuppressants, antibiotics, and antineoplastic agents. We also subjected PubMed records of TDM-related studies to a series of text-mining pipelines. Our analyses revealed how TDM research has evolved over the years, thereby serving as a cornerstone for forecasting future research trends.
- 15 November 2024
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 47 (11) , 1883-1892
Open AccessThe Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug Monitoring
Therapeutic drug monitoring (TDM) is a routine clinical practice used to individualize drug dosing to maintain drug efficacy and minimize the consequences of overexposure. TDM is applied to many drug classes, including immunosuppressants, antineoplastic agents, and antibiotics. Considerable effort has been made to establish routine TDM practices for each drug. However, because TDM has been developed within the context of specific drugs, there is insufficient understanding of historical trends within the field of TDM research as a whole. In this study, we employed text-mining approaches to explore trends in the TDM research field. We first performed a PubMed search to determine which drugs and drug classes have been extensively studied in the context of TDM. This investigation revealed that the most commonly studied drugs are tacrolimus, followed by cyclosporine and vancomycin. With regard to drug classes, most studies focused on immunosuppressants, antibiotics, and antineoplastic agents. We also subjected PubMed records of TDM-related studies to a series of text-mining pipelines. Our analyses revealed how TDM research has evolved over the years, thereby serving as a cornerstone for forecasting future research trends.